Literature DB >> 25579344

Recent advances in nanoparticle carriers for coordination complexes.

Mariana Rillo Sato, Patricia Bento da Silva, Rodrigo Alves de Souza, Karen Cristina dos Santos, Marlus Chorilli1.   

Abstract

Coordination compounds are substances in which a central metal atom is bonded to nonmetal atoms, or groups of atoms, called ligands. Examples include vitamin B12, hemoglobin, chlorophyll, dyes and pigments, as well as catalysts used in organic synthesis. Coordination compounds have received much attention in recent years. This interest was prompted by the discovery that several coordination compounds exhibit activity against bacteria, fungi and cancer. Some coordination compounds are not in clinical use, because of poor water solubility. Because they are unable to cross the lipid membranes of cells, bioavailability and efficacy are low. Some researchers have applied nanotechnology to coordination compounds, hoping to reduce the number of doses required and the severity of side effects, and also to improve biological activity. Nanotechnology can deliver active components in sufficient concentrations throughout treatment, guiding it to the desired location of action; conventional treatments do not meet these requirements. In this study we review some drug delivery systems based on nanotechnology, such as microemulsions (MEs), cyclodextrin (CD), polymeric nanoparticles (PN), solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), magnetic and gold nanoparticles (MNPs / AuNPs) and liquid crystalline systems (LC), and coordination compounds.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25579344     DOI: 10.2174/1568026615666150108145614

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  11 in total

1.  Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis.

Authors:  Mariana R Sato; João A Oshiro Junior; Rachel Ta Machado; Paula C de Souza; Débora L Campos; Fernando R Pavan; Patricia B da Silva; Marlus Chorilli
Journal:  Drug Des Devel Ther       Date:  2017-03-20       Impact factor: 4.162

Review 2.  Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis.

Authors:  Liliana Scorzoni; Ana C A de Paula E Silva; Caroline M Marcos; Patrícia A Assato; Wanessa C M A de Melo; Haroldo C de Oliveira; Caroline B Costa-Orlandi; Maria J S Mendes-Giannini; Ana M Fusco-Almeida
Journal:  Front Microbiol       Date:  2017-01-23       Impact factor: 5.640

3.  Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma.

Authors:  Yaoqi Ge; Yuejiao Zhong; Guozhong Ji; Qianling Lu; Xinyu Dai; Zhirui Guo; Peng Zhang; Gang Peng; Kangzhen Zhang; Yuntao Li
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

4.  A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis.

Authors:  Patricia B da Silva; Eduardo Sinésio de Freitas; Mariana Cristina Solcia; Paula Carolina de Souza; Monize Martins da Silva; Alzir Azevedo Batista; Carlos E Eismann; Ana Marta C M Rolisola; Amauri A Menegário; Rosilene Fressatti Cardoso; Marlus Chorilli; Fernando R Pavan
Journal:  Front Microbiol       Date:  2018-12-06       Impact factor: 5.640

Review 5.  Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges.

Authors:  Kiran Saleem; Zainab Khursheed; Christophe Hano; Iram Anjum; Sumaira Anjum
Journal:  Nanomaterials (Basel)       Date:  2019-12-09       Impact factor: 5.076

6.  Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp.

Authors:  Bruna Vidal Bonifácio; Matheus Aparecido dos Santos Ramos; Patrícia Bento da Silva; Kamila Maria Silveira Negri; Érica de Oliveira Lopes; Leonardo Perez de Souza; Wagner Vilegas; Fernando Rogério Pavan; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2015-08-10

7.  In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis.

Authors:  Patricia B da Silva; Paula C de Souza; Giovana Maria Fioramonti Calixto; Erica de O Lopes; Regina C G Frem; Adelino V G Netto; Antonio E Mauro; Fernando R Pavan; Marlus Chorilli
Journal:  Int J Mol Sci       Date:  2016-05-17       Impact factor: 5.923

8.  Polymeric Nanoparticle-Based Photodynamic Therapy for Chronic Periodontitis in Vivo.

Authors:  Laura Marise de Freitas; Giovana Maria Fioramonti Calixto; Marlus Chorilli; Juçaíra Stella M Giusti; Vanderlei Salvador Bagnato; Nikolaos S Soukos; Mansoor M Amiji; Carla Raquel Fontana
Journal:  Int J Mol Sci       Date:  2016-05-20       Impact factor: 5.923

Review 9.  Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?

Authors:  Aline Raquel Voltan; Guillermo Quindós; Kaila P Medina Alarcón; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2016-08-08

10.  Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.

Authors:  Yi Gou; Yao Zhang; Jinxu Qi; Shifang Chen; Zuping Zhou; Xiaoyang Wu; Hong Liang; Feng Yang
Journal:  Oncotarget       Date:  2016-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.